Pre-Tax Income: Company's earnings or loss before taxes on income have been accounted for.
Haemonetics Corporation (HAE) had Pre-Tax Income of $59.98M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$338.97M |
|
$44.74M |
|
$136.58M |
|
$202.39M |
|
$271.57M |
|
$67.40M |
|
$-7.42M |
|
|
Pre-Tax Income |
$59.98M |
$59.98M |
|
$44.74M |
|
$44.74M |
|
$44.74M |
|
$44.74M |
|
$67.40M |
|
$96.10M |
|
46.79M |
|
46.99M |
|
$0.96 |
|
$0.95 |
|
| Balance Sheet Financials | |
$943.67M |
|
$297.23M |
|
$1.55B |
|
$2.49B |
|
$539.87M |
|
$919.99M |
|
$1.04B |
|
$1.58B |
|
$911.45M |
|
$-115.11M |
|
$911.45M |
|
46.83M |
|
| Cash Flow Statement Financials | |
$222.28M |
|
$-92.93M |
|
$-76.96M |
|
$306.76M |
|
$363.37M |
|
$56.60M |
|
$24.70M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.75 |
|
-- |
|
-- |
|
0.50 |
|
1.34 |
|
59.71% |
|
19.88% |
|
19.88% |
|
-- |
|
17.69% |
|
13.20% |
|
$208.01M |
|
-- |
|
-- |
|
-- |
|
0.14 |
|
0.43 |
|
1.73 |
|
51.96 |
|
4.91% |
|
-38.87% |
|
1.80% |
|
2.44% |
|
$19.46 |
|
$4.43 |
|
$4.73 |
|